Biodesix (BDSX) Other financing activities (2019 - 2026)

Biodesix (BDSX) has reported Other financing activities for 8 consecutive years, with $28000.0 the latest figure, recorded in Q1 2026.

• Other financing activities for Q1 2026 came in at $28000.0, up 154.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $47000.0 (up 27.03% YoY), and the FY2025 annual result was $30000.0, down 31.82% from the prior year.
• Other financing activities was $28000.0 for Q1 2026 at Biodesix, down from $585000.0 in the prior quarter.
• Over five years, Other financing activities peaked at $3.6 million in Q4 2022 and troughed at -$880000.0 in Q2 2023.
• Average Other financing activities over 5 years is $310666.7, with a median of $28000.0 recorded in 2026.
• Year-over-year, Other financing activities jumped 9800.0% in 2022 and plunged 988.89% in 2023.
• Over 5 years, Other financing activities stood at $3.6 million in 2022, then sank by 74.64% to $912000.0 in 2023, then tumbled by 64.91% to $320000.0 in 2024, then soared by 82.81% to $585000.0 in 2025, then plunged by 95.21% to $28000.0 in 2026.
• Per Business Quant data, the three most recent Other financing activities figures were $28000.0 in Q1 2026, $585000.0 in Q4 2025, and -$582000.0 in Q3 2025.